FR2359607A1 - Nouvelle composition pharmaceutique permettant une liberation controlee de la substance active - Google Patents

Nouvelle composition pharmaceutique permettant une liberation controlee de la substance active

Info

Publication number
FR2359607A1
FR2359607A1 FR7723022A FR7723022A FR2359607A1 FR 2359607 A1 FR2359607 A1 FR 2359607A1 FR 7723022 A FR7723022 A FR 7723022A FR 7723022 A FR7723022 A FR 7723022A FR 2359607 A1 FR2359607 A1 FR 2359607A1
Authority
FR
France
Prior art keywords
pharmaceutical composition
active substance
controlled release
new pharmaceutical
composition allowing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7723022A
Other languages
English (en)
Other versions
FR2359607B1 (fr
Inventor
Guy Jehl
Jean-Pierre Nougaret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2359607A1 publication Critical patent/FR2359607A1/fr
Application granted granted Critical
Publication of FR2359607B1 publication Critical patent/FR2359607B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une composition pharmaceutique susceptible de libérer de façon controlée une substance active dans le tractus intestinal et sa préparation. La nouvelle composition pharmaceutique contient une substance active choisie parmi les arylalcanolamines et les aryloxyalcanolamines, et un agent tensio-actif anionique acceptable du point de vue physiologique, choisi parmi les monosulfates d'alcools gras supérieurs. La composition pharmaceutique de l'invention convient notamment à l'administration d'agents de blocage des récepteurs beta -adrénergiques et d'agents anti-arythmiques.
FR7723022A 1976-07-27 1977-07-27 Nouvelle composition pharmaceutique permettant une liberation controlee de la substance active Granted FR2359607A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH958876 1976-07-27

Publications (2)

Publication Number Publication Date
FR2359607A1 true FR2359607A1 (fr) 1978-02-24
FR2359607B1 FR2359607B1 (fr) 1980-02-22

Family

ID=4353539

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7723022A Granted FR2359607A1 (fr) 1976-07-27 1977-07-27 Nouvelle composition pharmaceutique permettant une liberation controlee de la substance active

Country Status (27)

Country Link
JP (1) JPS5315411A (fr)
AR (1) AR216479A1 (fr)
AT (1) AT369987B (fr)
AU (1) AU515738B2 (fr)
BE (1) BE857122A (fr)
CA (1) CA1095833A (fr)
CY (1) CY1261A (fr)
DE (1) DE2732335C2 (fr)
DK (1) DK325677A (fr)
ES (1) ES461020A1 (fr)
FI (1) FI772217A (fr)
FR (1) FR2359607A1 (fr)
GB (1) GB1589982A (fr)
GR (1) GR65014B (fr)
HK (1) HK81884A (fr)
HU (1) HU178340B (fr)
IE (1) IE45534B1 (fr)
IL (1) IL52587A (fr)
KE (1) KE3441A (fr)
MY (1) MY8400057A (fr)
NL (1) NL176227C (fr)
NO (1) NO149874C (fr)
NZ (1) NZ184722A (fr)
PT (1) PT66850B (fr)
SE (1) SE437469B (fr)
SG (1) SG53884G (fr)
ZA (1) ZA774536B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2462911A1 (fr) * 1979-08-16 1981-02-20 Sandoz Sa Nouvelles compositions pharmaceutiques solides, sous forme de doses unitaires, a enrobage enterique a base d'un sel hydrosoluble de la cellulose partiellement estirifiee par un acide dicarboxylique
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
JPS5748908A (en) * 1980-09-08 1982-03-20 Kyorin Pharmaceut Co Ltd Prolonged release type nicomol pharmaceutical
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
US4540566A (en) * 1984-04-02 1985-09-10 Forest Laboratories, Inc. Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
JPS61254522A (ja) * 1985-05-02 1986-11-12 Takada Seiyaku Kk 錠剤組成物
JPS62246512A (ja) * 1986-04-18 1987-10-27 Fujisawa Pharmaceut Co Ltd 反復作用製剤
GB9714675D0 (en) * 1997-07-11 1997-09-17 Smithkline Beecham Plc Novel composition
DE19959419A1 (de) 1999-12-09 2001-06-21 Ratiopharm Gmbh Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1002211A (en) * 1962-06-12 1965-08-25 William Eric Gaunt Method of preparing sustained release pharmaceutical tablets
DE1944693A1 (de) * 1968-09-03 1970-04-30 Banker Dr Gilbert S Arzneimittelzubereitung
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions
GB1301849A (fr) * 1969-12-15 1973-01-04

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1002211A (en) * 1962-06-12 1965-08-25 William Eric Gaunt Method of preparing sustained release pharmaceutical tablets
DE1944693A1 (de) * 1968-09-03 1970-04-30 Banker Dr Gilbert S Arzneimittelzubereitung
GB1301849A (fr) * 1969-12-15 1973-01-04
US3558768A (en) * 1969-12-19 1971-01-26 Sterling Drug Inc Sustained release pharmaceutical compositions

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2462911A1 (fr) * 1979-08-16 1981-02-20 Sandoz Sa Nouvelles compositions pharmaceutiques solides, sous forme de doses unitaires, a enrobage enterique a base d'un sel hydrosoluble de la cellulose partiellement estirifiee par un acide dicarboxylique
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation

Also Published As

Publication number Publication date
IL52587A0 (en) 1977-10-31
DK325877A (da) 1978-01-20
GB1589982A (en) 1981-05-20
NO772575L (no) 1978-01-30
DK325677A (da) 1978-01-28
DE2732335C2 (de) 1983-01-20
AR216479A1 (es) 1979-12-28
MY8400057A (en) 1984-12-31
HK81884A (en) 1984-11-25
DE2732335A1 (de) 1978-02-02
SG53884G (en) 1985-03-08
SE7708265L (sv) 1978-01-28
KE3441A (en) 1984-09-14
ES461020A1 (es) 1979-05-01
AT369987B (de) 1983-02-25
ATA541377A (de) 1982-07-15
HU178340B (en) 1982-04-28
IE45534L (en) 1978-01-27
CY1261A (en) 1984-11-23
AU515738B2 (en) 1981-04-30
ZA774536B (en) 1979-02-28
BE857122A (fr) 1978-01-25
NO149874B (no) 1984-04-02
CA1095833A (fr) 1981-02-17
PT66850B (fr) 1979-03-13
NZ184722A (en) 1980-10-24
FI772217A (fr) 1978-01-28
SE437469B (sv) 1985-03-04
JPS5315411A (en) 1978-02-13
IE45534B1 (en) 1982-09-22
AU2730177A (en) 1979-02-01
FR2359607B1 (fr) 1980-02-22
NL176227B (nl) 1984-10-16
NL7708162A (nl) 1978-01-31
NL176227C (nl) 1985-03-18
GR65014B (en) 1980-06-13
JPS5726650B2 (fr) 1982-06-05
NO149874C (no) 1984-07-11
IL52587A (en) 1980-09-16
PT66850A (fr) 1977-08-01

Similar Documents

Publication Publication Date Title
EP0759773B1 (fr) Emulsion specifique de la glande lacrymale pour application locale sur les tissus de l' il
FR2359607A1 (fr) Nouvelle composition pharmaceutique permettant une liberation controlee de la substance active
NEWCOMER et al. A melanosis of the face (chloasma)
KR0148748B1 (ko) 사이클로스포린을 함유하는 약학조성물
JPH0623106B2 (ja) 高眼圧改善・緑内障処置剤
KR20100095425A (ko) 천심련 추출물
RU2191008C2 (ru) АНТАГОНИСТ-ЛИГАНД RAR-γ ИЛИ АГОНИСТ-ЛИГАНД RAR-α В КАЧЕСТВЕ ИНГИБИТОРА АПОПТОЗА
US4325965A (en) Agent for preventing or treating psoriasis
Moqbel et al. Enteral and systemic release of leukotrienes during anaphylaxis of Nippostrongylus brasiliensis-primed rats.
Anderson et al. Disposition of topical flurbiprofen in normal and aphakic rabbit eyes
IT9020968A1 (it) Composto farmaceutico a base di un antocianidina per il trattamento di malattie oftalmiche
US5011824A (en) Rectal motilin preparation
US4035510A (en) Treatment of acne utilizing N-methyldiethanolamine
EP0378413A2 (fr) Compositions pour le traitement topique de maladies cutanées
Baatz et al. Modulation of leukocyte-endothelium interaction by nitric oxide synthase inhibitors: effects on leukocyte adhesion in endotoxin-induced uveitis
JPH06100466A (ja) ストレス性脳神経細胞器質障害防御剤
EP0356272B1 (fr) Médicaments destinés à regulariser les sécrétions hormonales et à traiter la stérilité chez la femme et les animaux femelles
BE899917Q (fr) Compositions pharmaceutiques de reglisse deglycyrrhizinee.
FR2361869A1 (fr) Produit contraceptif masculin contenant du trifluoroethanol
Fujino et al. Phagocytosis and autophagy in the apical gastrodermis of the lung fluke, Paragonimus ohirai
CA2309033C (fr) Emulsions specifiques de glandes lacrymales pour application topique sur le tissu oculaire
DE2759793C2 (de) Mittel zur Verbesserung der Durchblutung und Wundheilung
WO2022266079A1 (fr) Compositions de cyclosporine et méthodes d'utilisation
FR2656303A1 (fr) Solution buvable d'un derive des benzodiazepines et son application pharmacologique.
Wendling et al. In vivo investigations on microcirculatory disturbances induced by crenated erythrocytes following norepinephrine application

Legal Events

Date Code Title Description
ST Notification of lapse